IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19788

Article Published : 8107

Total Authors : 21429

Total Reviewer : 771

Total Countries : 147

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Bioanalytical method development and validation of LC-ESI-MS/MS for estimation of Regorafenib monohydrate in K3EDTA human plasma.
Authors Name: Patel Krupa Jagdeeshbhai , Dr. Tulsidas Misra , Mr. Gajendra Solanki , Ms. Rajvi Mahida
Download E-Certificate: Download
Author Reg. ID:
IJRTI_189685
Published Paper Id: IJRTI2404135
Published In: Volume 9 Issue 4, April-2024
DOI:
Abstract: The objective is to develop and validate a bioanalytical method of LC-ESI-MS/MS for estimation Regorafenib monohydrate in K3EDTA human plasma. To quantify regorafenib monohydrate in human plasma, a simple, rapid, and sensitive isocratic reverse-phase liquid chromatography - tandem mass spectrometric method was developed. It was equipped with a Turbo Ion Spray (TIS) source and operated in the Multiple Reaction Monitoring (MRM) and Positive Ion modes. Analyte and ISTD were extracted from human plasma using the Liquid Liquid Extraction (LLE) method. Mobile Phase Composition was 2mM ammonium formate in water: Acetonitrile (30:70% v/v) for separation using ACE C18 column (100mm × 4.6mm, 5µm). With a total run time of 4.5 minutes, the drug and ISTD were retained at 2.4 minutes. Following optimization, the bioanalytical method was validated according to USDA and EMA bioanalysis guidelines. Liquid Liquid Extraction (LLE) was used to prepare the sample, and it produced clean extracts with recovery of 71.40% for ISTD and 76.64% for drug, respectively. Over the dynamic range of 10 - 25000 ng/ml, the LC-MS/MS method's analyte response was linear, with a regression coefficient r2 in the range of 0.9992-0.9994. At the Lower Limit of Quantification (LLOQ), the Accuracy was within the accepted range of ±20%, and at all other concentrations in the linear range, it was within ±15%. Thus, a simple, precise and sensitive isocratic reverse-phase liquid chromatographic tandem mass spectrometric method was developed to quantify Regorafenib Monohydrate in KEDTA human plasma. This method can be effectively used for BA/BE, toxicokinetic, and pharmacokinetic studies in human subjects.
Keywords: LC-ESI-MS/MS, Regorafenib, Bioanalytical Method Development, Validation.
Cite Article: "Bioanalytical method development and validation of LC-ESI-MS/MS for estimation of Regorafenib monohydrate in K3EDTA human plasma.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 4, page no.995 - 1003, April-2024, Available :http://www.ijrti.org/papers/IJRTI2404135.pdf
Downloads: 000205192
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2404135
Registration ID:189685
Published In: Volume 9 Issue 4, April-2024
DOI (Digital Object Identifier):
Page No: 995 - 1003
Country: vapi,valsad, Gujrat, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2404135
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2404135
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner